Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2021 | Impacts of COVID-19 infection on patients with urological cancers undergoing surgery

Chuanyu Gao, MD, British Urology Researchers in Surgical Training, London, UK, discusses the impact of the COVID-19 pandemic on surgical practices for the treatment of patients with urological cancer. Dr Gao reports that patients who contract COVID-19 within 30 days of undergoing elective surgery have poorer outcomes and are more likely to experience complications than patients who do not contract COVID-19. Dr Gao comments on the need for separate sites for elective surgery to reduce the risk of contracting COVID-19 for surgical patients. Dr Gao also highlights the COVIDSurg-Cancer study, which is investigating the medium-term impacts of COVID-19 on urological cancer outcomes. This interview took place at the virtual European Association of Urology (EAU) Virtual Meeting 2021.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.